The National Institutes of Health’s Rapid Acceleration of Diagnostics initiative announced on Thursday that it has awarded $77.7 million to develop and manufacture 12 new rapid diagnostic tests for SARS-CoV-2. Source: Genomeweb
Ad Banner
Show Comments (0)
Hide Comments (0)
Subscribe
Login
0 Comments
Oldest
